GHRS
#2110
GH Research PLC - Ordinary Shares
27.9 4 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.48%
Changement Mensuel
-0.21%
Evolution sur 6 mois
+93.36%
Changement Annuel
+97.32%
Clôture Précédente
28.6 5
Open
27.9 4
Low
27.9 4
High
27.9 4
Volume
25
Financials
- Market Capitalization 1.73 B
- Employee 73
- Founded 2018
- CEO Theis Terwey
- Website www.ghres.com
- Headquarter Ireland
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2084 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.34 USD | -2.91% | -2.05% | +11.71% | -27.23% | 1.79 B USD | ||
| 2106 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.54 USD | -3.08% | -0.76% | +1.93% | +18.42% | 1.74 B USD | ||
| 2122 |  AAPG Ascentage Pharma Group International - American Depository Shar | 18.28 USD | -2.40% | +8.62% | -0.81% | -26.88% | 1.71 B USD | ||
| 2143 |  ANAB AnaptysBio, Inc. - Common Stock | 56.28 USD | -1.76% | -1.19% | +6.23% | +59.89% | 1.64 B USD |